Biodesix (BDSX) Capital Expenditures Growth (3y) (2022 - 2026)
Biodesix (BDSX) Capital Expenditures Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn | -6.49% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | -3.55% |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn | 10.06% |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn | 7.36% |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn | 139.42% |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn | -5.23% |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn | -1.12% |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn | 9.89% |
| 10 | Biodesix | 208.57 Mn | 183.00 Mn | 21.35 Mn | -78.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.07% |
| Dec 31, 2025 | -65.73% |
| Sep 30, 2025 | -72.47% |
| Jun 30, 2025 | 32.00% |
| Mar 31, 2025 | 68.19% |
| Dec 31, 2024 | -33.91% |
| Sep 30, 2024 | 45.17% |
| Jun 30, 2024 | 119.92% |
| Mar 31, 2024 | 44.94% |
| Dec 31, 2023 | -256.27% |
| Sep 30, 2023 | 67.15% |
| Jun 30, 2023 | 263.14% |
| Mar 31, 2023 | 327.86% |
| Dec 31, 2022 | 75.52% |